Literature DB >> 19871592

STUDIES ON THE TOXICITY OF INFLUENZA VIRUSES : I. THE EFFECT OF INTRACEREBRAL INJECTION OF INFLUENZA VIRUSES.

G Henle1, W Henle.   

Abstract

Intracerebral injection of preparations of influenza viruses into mice led to tonic and clonic convulsions and death in tetanus, usually within 24 to 72 hours. Histological examination revealed the destruction of the ependymal lining of the ventricles as the dominant finding. These reactions were obtained in four different strains of mice as well as in rats, guinea pigs, and hamsters. They were observed in mice after injection of mouse and egg-adapted virus, and all strains of virus tested gave these responses as long as sufficient quantities of the agents were injected. Control materials, such as normal allantoic fluids, particulate components of normal chorio-allantoic membranes, and suspensions of normal murine lungs, gave uniformly negative results. Activation of a latent virus as well as the inadvertent admixture of a neurotropic agent to the influenza cultures was excluded. Propagation of the influenza viruses in the central nervous system could not be demonstrated and, in fact, the agents were no longer demonstrable in 4 days. It was concluded that the observed neurological reactions were the result of toxic activities rather than of virus propagation. Comparison between the infectivity, hemagglutinating capacity, and the toxic activity showed that preparations with the higher titers of virus and hemagglutinin were also the more toxic ones. The toxic agents could not be separated from the infectious particles by the use of such technics as differential high speed centrifugation, adsorption onto and elution from chicken red cells, and precipitation by protamine. The toxic effect of influenza A virus preparations was specifically neutralized by anti-influenza A and not by anti-influenza B serum, and conversely. In addition, antigenic differences were noted between two strains of influenza A virus by this method of testing.

Entities:  

Keywords:  INFLUENZA/virus

Mesh:

Substances:

Year:  1946        PMID: 19871592      PMCID: PMC2135619          DOI: 10.1084/jem.84.6.623

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

Review 1.  THE COMPLICATIONS OF INFLUENZA.

Authors:  C H STUART-HARRIS
Journal:  Postgrad Med J       Date:  1963-10       Impact factor: 2.401

2.  [Histopathology and pathogenesis of experimental JHM-virus encephalomyelitis in apes].

Authors:  G KERSTING; E PETTE
Journal:  Dtsch Z Nervenheilkd       Date:  1956

3.  Studies on interference between influenza and equine encephalomyelitis viruses.

Authors:  R W SCHLESINGER
Journal:  Arch Gesamte Virusforsch       Date:  1951

4.  Mechanism of production of pulmonary lesions in mice by Newcastle disease virus (NDV).

Authors:  H S GINSBERG
Journal:  J Exp Med       Date:  1951-09       Impact factor: 14.307

5.  Reproduction of influenza viruses; quantitative investigations with particle enumeration procedures on the dynamics of influenza A and B virus reproduction.

Authors:  F L HORSFALL
Journal:  J Exp Med       Date:  1955-10-01       Impact factor: 14.307

6.  The production of fever by influenzal viruses; factors influencing the febrile response to single injections of virus.

Authors:  R R WAGNER; I L BENNETT; V S LeQUIRE
Journal:  J Exp Med       Date:  1949-10       Impact factor: 14.307

7.  Comparative biochemical studies on normal and on poliomyelitis virus-infected tissue cultures. V. Profund alteration of acid and alkaline phosphatase activity in infected rhesus kidney cells.

Authors:  E KOVACS
Journal:  J Exp Med       Date:  1956-10-01       Impact factor: 14.307

Review 8.  Diagnosis of viral disease and the advent of antiviral drugs.

Authors:  E C Herrmann; J A Herrmann
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

9.  Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses.

Authors:  Mohammad Al Farroukh; Irina Kiseleva; Ekaterina Bazhenova; Ekaterina Stepanova; Ludmila Puchkova; Larisa Rudenko
Journal:  Vaccines (Basel)       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.